Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Frontiers in Physiology|December 12, 2018
Diabetes and Arrhythmias: Pathophysiology, Mechanisms and Therapeutic OutcomesLaurel A GrisantiCurrent Protocols|January 5, 2023
Radioligand Binding to Quantify Adrenergic Receptor Expression in the HeartLaurel A GrisantiFrontiers in Physiology|June 1, 2026
Adrenergic receptors on immune cells in cardiovascular disease: signaling plasticity, biased agonism, and therapeutic opportunitiesLaurel A Grisanti, Soraya NekouianFrontiers in Cardiovascular Medicine|September 16, 2021
A Dual Role for Death Receptor 5 in Regulating Cardiac Fibroblast FunctionMiles A Tanner, Laurel A GrisantiFrontiers in Physiology|October 12, 2020
The Dynamic Interplay Between Cardiac Inflammation and FibrosisToby P Thomas, Laurel A GrisantiJournal of Cardiovascular Pharmacology|January 7, 2017
Cardiac GPCR-Mediated EGFR Transactivation: Impact and Therapeutic ImplicationsLaurel A Grisanti, Shuchi Guo, Douglas G TilleyThe Journal of Pharmacology and Experimental Therapeutics|May 25, 2025
Death receptor 5 agonists mitigate cardiac pathology in a chronic isoproterenol-induced cardiac remodeling and dysfunctionMiles A Tanner, Katrina Dougherty, Laurel A GrisantiJournal of Molecular and Cellular Cardiology|September 2, 2019
Death receptor 5 contributes to cardiomyocyte hypertrophy through epidermal growth factor receptor transactivationMiles A Tanner, Toby P Thomas, Laurel A GrisantiAmerican Journal of Physiology. Heart and Circulatory Physiology|August 20, 2021
Immune cell β2-adrenergic receptors contribute to the development of heart failureMiles A Tanner, Charles A Maitz, Laurel A GrisantiPageof 5